Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Prestige Consumer Healthcare (PBH)

Prestige Consumer Healthcare Q3 revenue falls 2.4% to $283.4 million; outlook narrowed

Negative Impact 4 of 5 earnings Written later

Prestige Consumer Healthcare reported fiscal third-quarter 2026 results for the quarter ended December 31, 2025, with revenue of $283.4 million, down 2.4% from a year earlier, and diluted EPS of $0.97 versus $1.22. The company narrowed its fiscal 2026 revenue outlook to approximately $1.1 billion, and its adjusted diluted EPS outlook to approximately $4.54, the low end of its prior range, while keeping free cash flow guidance at $245 million or more.

Key points

  • Q3 revenue of $283.4 million, down from $290.3 million; the company attributed the decline mainly to limited ability to supply demand for Clear Eyes.
  • Q3 diluted EPS of $0.97 versus $1.22; adjusted diluted EPS of $1.14 versus $1.22 in the prior-year quarter.
  • Fiscal 2026 revenue outlook narrowed to approximately $1,100 million from $1,100 million to $1,115 million; organic revenue decline now approximately 3.0%.
  • Repurchased approximately 0.8 million shares for $45.8 million in Q3; Pillar5 Pharma acquisition closed in December.

The filing

CompanyPrestige Consumer Healthcare (PBH)
Form8-K, current report
Filed with the SECFeb 5, 2026, 6:04 AM ET
Accession number0001295947-26-000006

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:54 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.